Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behçet's disease

References

1. ATS 1997; Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–S25 [CrossRef]
   [Google Scholar]
2. Barham G. S., Hargreaves D. G. 2006; Mycobacterium kansasii olecranon bursitis. J Med Microbiol 55:1745–1746 [CrossRef]
   [Google Scholar]
3. Boulman N., Rozenbaum M., Slobodin G., Rosner I. 2006; Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis. Clin Exp Rheumatol 24:723
   [Google Scholar]
4. BTS 2000; Management of opportunistic mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 55:210–218 [CrossRef]
   [Google Scholar]
5. Chang J., Girgis L. 2007; Clinical use of anti-TNF- α biological agents – a guide for GPs. Aust Fam Physician 36:1035–1038
   [Google Scholar]
6. Dawson D. J., Blacklock Z. M., Ashdown L. R., Botteger E. C. 1995; Mycobacterium asiaticum as the probable causative agent in a case of olecranon bursitis. J Clin Microbiol 33:1042–1043
   [Google Scholar]
7. Fallon J. C., Patchett S., Gulmann C., Murphy G. M. 2008; Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab. Clin Exp Dermatol 33:43–45
   [Google Scholar]
8. Friedman N. D., Sexton D. J. 2001; Bursitis due to Mycobacterium goodii , a recently described, rapidly growing mycobacterium. J Clin Microbiol 39:404–405 [CrossRef]
   [Google Scholar]
9. Maloney J. M., Gregg C. R., Stephens D. S., Manian F. A., Rimland D. 1987; Infections by Mycobacterium szulgai in humans. Rev Infect Dis 9:1120–1126 [CrossRef]
   [Google Scholar]
10. Marie I., Heliot P., Roussel F., Hervé F., Muir J. F., Levesque H. 2005; Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology 44:1201–1202 [CrossRef]
    [Google Scholar]
11. Martín-Aspas A., Guerro-Sánchez F., García-Martos P., González-Moya E., Medina-Varo F., Girón González J. A. 2008; Bilateral pneumonia by Mycobacterium aurum in a patient receiving infliximab therapy. J Infect 57:167–169 [CrossRef]
    [Google Scholar]
12. Mufti A. H., Toye B. W., Mckendry R. R., Angel J. B. 2005; Mycobacterium abscessus infection after use of tumour necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumour necrosis factor alpha inhibitor use. Diagn Microbiol Infect Dis 53:233–238 [CrossRef]
    [Google Scholar]
13. Okubo H., Iwamoto M., Yoshio T., Okazaki H., Kato T., Bandoh M., Minota S. 2005; Rapidly aggravated Mycobacterium avium infection in a patient with rheumatoid arthritis treated with infliximab. Mod Rheumatol 15:62–64 [CrossRef]
    [Google Scholar]
14. Rallis E., Koumantaki-Mathioudaki E., Frangoulis E., Chatziolou E., Katsambas A. 2007; Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 8:385–388 [CrossRef]
    [Google Scholar]
15. Rutten M. J., Van der Berg J. C., Van der Hoogen F. H., Lemmens J. A. 1998; Non-tuberculous mycobacterial bursitis and arthritis of the shoulder. Skeletal Radiol 27:33–35 [CrossRef]
    [Google Scholar]
16. Salvana E. M. T., Cooper G. S., Salata R. A. 2007; Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect 55:484–487 [CrossRef]
    [Google Scholar]
17. Slifman N. R., Gershon S. K., Lee J. H., Edwards E. T., Braun M. M. 2003; Listeria monocytogenes infection as a complication of treatment with tumour necrosis factor α -neutralizing agents. Arthritis Rheum 48:319–324 [CrossRef]
    [Google Scholar]
18. Weinstein P. S., Canoso J. J., Wohlgethan J. R. 1984; Long-term follow-up of corticosteroid injection for traumatic olecranon bursitis. Ann Rheum Dis 43:44–46 [CrossRef]
    [Google Scholar]